17-48769149-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001130918.3(TTLL6):c.2516A>T(p.Asn839Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000564 in 1,613,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001130918.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTLL6 | NM_001130918.3 | c.2516A>T | p.Asn839Ile | missense_variant | 15/16 | ENST00000393382.8 | NP_001124390.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTLL6 | ENST00000393382.8 | c.2516A>T | p.Asn839Ile | missense_variant | 15/16 | 2 | NM_001130918.3 | ENSP00000377043.3 |
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000836 AC: 21AN: 251070Hom.: 0 AF XY: 0.0000737 AC XY: 10AN XY: 135684
GnomAD4 exome AF: 0.0000328 AC: 48AN: 1461846Hom.: 0 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 727220
GnomAD4 genome AF: 0.000283 AC: 43AN: 152146Hom.: 0 Cov.: 32 AF XY: 0.000323 AC XY: 24AN XY: 74332
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2024 | The c.2516A>T (p.N839I) alteration is located in exon 15 (coding exon 15) of the TTLL6 gene. This alteration results from a A to T substitution at nucleotide position 2516, causing the asparagine (N) at amino acid position 839 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at